scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Stirling D | |
Ludlam CA | |||
Kerr R | |||
P2860 | cites work | Production of hybridoma growth factor by human monocytes. | Q52827130 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
P304 | page(s) | 3-12 | |
P577 | publication date | 2001-10-01 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Interleukin 6 and haemostasis | |
P478 | volume | 115 |
Q44927461 | Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes |
Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
Q44662101 | Age-related inflammatory cytokines and disease |
Q35995696 | Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway |
Q34942534 | Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men. |
Q51139037 | Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis. |
Q46678880 | Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study |
Q34335486 | Biomarkers and HIV-associated cardiovascular disease |
Q38174213 | Biomarkers in atrial fibrillation: an overview |
Q96618090 | COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking |
Q48560063 | Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture |
Q43098741 | Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel |
Q47927559 | Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases |
Q36673531 | Coagulation interventions in experimental human endotoxemia |
Q35926044 | Comparative aspects of blood coagulation |
Q38669886 | Comparative assessment of immune complex-mediated hypersensitivity reactions with biotherapeutics in the non-human primate: Critical parameters, safety and lessons for future studies |
Q40322916 | Crimean-Congo hemorrhagic fever virus activates endothelial cells |
Q47201581 | D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection. |
Q47903838 | Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice |
Q34662795 | Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients |
Q84325750 | Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients |
Q35597282 | Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects |
Q36331121 | Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia |
Q37375244 | Effects of gender and dementia severity on Alzheimer's disease caregivers' sleep and biomarkers of coagulation and inflammation |
Q34497358 | Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation |
Q41131826 | Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer |
Q53660624 | Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. |
Q51654721 | Elevated levels of tumor necrosis factor alpha and mortality in centenarians. |
Q96960526 | Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study |
Q46173252 | Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation |
Q36154476 | Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state |
Q37621119 | Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia. |
Q33399140 | Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy |
Q48218551 | Growth Hormone (GH) and Cardiovascular System |
Q37603069 | HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma |
Q47339155 | Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation |
Q44131690 | High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation |
Q41623499 | High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump coronary artery bypass grafting |
Q30514057 | In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling |
Q24815899 | Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis |
Q79215207 | Increased Levels of Hemostatic Proteins are Independent of Inflammation in Glycogen Storage Disease Type Ia |
Q54049063 | Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent. |
Q52149539 | Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. |
Q42844870 | Inflammatory markers and exposure to occupational air pollutants |
Q36283496 | Innate immunity and atherogenesis |
Q57416312 | Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men |
Q35913178 | Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study |
Q37161467 | Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells |
Q43148854 | Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. |
Q42905188 | Linking air pollution exposure with thrombosis |
Q28755180 | Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review |
Q37096276 | Long-term variability of inflammatory markers and associated factors in a population-based cohort |
Q35061559 | Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension |
Q99416910 | Massive pulmonary embolism following recovery from COVID-19 infection: inflammation, thrombosis and the role of extended thromboprophylaxis |
Q42460075 | Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy |
Q41602019 | Monocytes regulate systemic coagulation and inflammation in abdominal sepsis |
Q92572683 | Multiple plasma metals, genetic risk and serum C-reactive protein: A metal-metal and gene-metal interaction study |
Q28728107 | On-versus Off-Pump Coronary Artery Bypass Grafting: No Difference in Early Postoperative Kidney Function Based on TNF-α or C-Reactive Protein |
Q59798105 | Particulate Matter Air Pollution: Effects on the Cardiovascular System |
Q27348345 | Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms |
Q58093826 | Pathological effects of ionizing radiation: endothelial activation and dysfunction |
Q36201980 | Physical activity and modulation of systemic low-level inflammation |
Q92201372 | Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma |
Q80347661 | Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension |
Q37142044 | Pleiotropic effects of thiazolidinediones |
Q41177479 | Portal Venous Thrombosis-Disseminated Tuberculosis in Rheumatoid Arthritis |
Q43004006 | Portopulmonary hypertension in cirrhosis: the pathogenetic challenge |
Q35148377 | Post-stroke inflammatory response: effects of stroke evolution and outcome |
Q44373643 | Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people |
Q36902376 | Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study. |
Q37059793 | Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy |
Q79322013 | Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure |
Q37432302 | Promoter Polymorphism (-174, G/C) of Interleukin-6 and Arterial Thromboembolic Events: A Meta-Analysis |
Q42667897 | Sex differences in the association between stressor-evoked interleukin-6 reactivity and C-reactive protein |
Q49724056 | Significance of venous thromboembolism in women with uterine carcinosarcoma |
Q36513378 | Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study |
Q42750303 | Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice. |
Q45857189 | Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice |
Q107739555 | The Many Faces of JAKs and STATs Within the COVID-19 Storm |
Q37017858 | The assessment of proinflammatory cytokines in the patients with the history of cerebral venous sinus thrombosis |
Q33889580 | The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms |
Q55387461 | The effect of salusin-β on expression of pro- and anti-inflammatory cytokines in human umbilical vein endothelial cells (HUVECs). |
Q36147794 | Thrombosis in systemic lupus erythematosus: a review article |
Q37348644 | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
Q51244914 | Treadmill exercise alleviates diabetic cardiomyopathy by suppressing plasminogen activator inhibitor expression and enhancing eNOS in streptozotocin-induced male diabetic rats. |
Q38370197 | Venous thromboembolism in systemic autoimmune diseases: A narrative review with emphasis on primary systemic vasculitides |
Q41519093 | Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. |
Q90669258 | Young Women With Coronary Artery Disease Exhibit Higher Concentrations of Interleukin-6 at Baseline and in Response to Mental Stress |
Q30581666 | β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis |
Search more.